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BBMT EARNS ISI IMPACT FACTOR:
4TH AMONG TRANSPLANT JOURNALS
One of the milestones of growth
for a young medical journal is getting
its first “impact factor.” Biology of
Blood and Marrow Transplantation
has earned an ISI impact factor of
2.919.
In an effort to quantify and com-
pare medical journals, the Institute for
Scientific Information (ISI) computes
and assigns a numerical factor to
peer-reviewed journals. The number
is based on the frequency with which
the journal’s articles are cited in other
scientific publications in a given year.
To put the 2.919 number into per-
spective, BBMT ranked 4th among 17
transplant journals, 16th among 61
hematology journals, and 34th among
119 immunology journals.
“This is a superb start for our first
year with an ISI ranking,” ASBMT Pres-
ident Joseph Antin, MD, said. “I join
our officers, directors, and members
in congratulating the current and
past editors, Drs. Bob Korngold, Karl
Blume, and Richard O’Reilly, as well
as the editorial board and the con-
tributing authors, for this achieve-
ment.”
OCT. 20 ABSTRACT DEADLINE
FOR TANDEM BMT MEETINGS
Oct. 20 is the deadline for abstracts
for the 2004 Tandem BMT Meetings
that will be held next Feb. 13–17 in
Orlando. Abstracts can be submitted
online at the ASBMT Web site, www.
asbmt.org.
Organizers for the Tandem BMT
Meetings have set aside time for oral
presentation of 66 abstracts, selected
by the Abstract Review Committees.
Many other abstract authors will be
invited to present posters in sessions
on Saturday, Feb. 14, and Monday,
Feb. 16.
ASBMT gives three awards of
$1,000 each for the best basic re-
search abstracts, and IBMTR/ABMTR
presents three awards of $1,000
each for the best clinical research ab-
stracts—as determined by the Ab-
stract Review Committees.
Abstracts can be submitted in any
of 15 categories of clinical and labo-
ratory research. For the first time,
there also will be a category for ab-
stracts submitted by pharmacists, just
as there have been categories for
nurses and research associates/data
managers in recent years.
TANDEM BMT MEETINGS
REGISTRATION NOW OPEN
Registration is open for the 2004
Tandem BMT Meetings that will be
held Feb. 13–17 at the Coronado
Springs Resort in Orlando.
Visit the ASBMT Web site, www.
asbmt.org, for both online registra-
tion and information about housing.
The deadline for the early registration
fee discount is Oct. 20.
If you think that the price of every-
thing keeps going up and up, you
are apparently not thinking about the
Tandem BMT Meetings. This will be
the second time that the joint an-
nual meetings of ASBMT and IBMTR/
ABMTR have convened at the Coro-
nado Springs Resort—we were there
in 2002—and meeting participants
will be spending less this time on
both registration and housing:
• Early registration for ASBMT mem-
bers associated with an IBMTR/
ABMTR–participating transplant cen-
ter is $450. (If you attended the
meeting in 2002 it was $495.)
• Accommodations at the Coronado
Springs Resort are $138 for a single
or double. (If you attended the
meeting in 2002 it was $175.)
“The 9 percent decrease in meeting
registration fee and 21 percent de-
crease in room costs are part of our
effort to make the meeting as eco-
nomical as possible, while presenting
the premiere annual program of
blood and marrow transplantation
clinical investigations, laboratory re-
search, and patient care,” said ASBMT
President Joseph Antin, MD.
“If you remember that the meeting
registration fee includes all scientific
sessions and workshops, exhibits, so-
cial events, and meals throughout the
five days, you would have trouble
finding a deal this good on eBay,” he
said.
In addition to the basic and clini-
cal research programs, five parallel
conferences and courses will be
held for:
• BMT Pharmacists (Feb. 12–13)
• Clinical Research Associates (Feb.
12–14)
• BMT Center Medical Directors (Feb.
13)
• BMT Center Administrators (Feb.
14–15)
• Oncology Nurses (Feb. 15–17)
The preliminary program was out-
lined in a brochure sent to ASBMT
Members in July. Updates are posted




Postdoctoral fellows and physi-
cians-in-training for blood and mar-
row transplantation are eligible for
free membership in the American So-
ciety for Blood and Marrow Trans-
plantation.
Through October, the annual dues
will be waived for new fellows-in-
training who join the Society. Usually
the annual dues for a trainee are $75.
The program to recruit in-training
members is supported by an unre-
stricted educational grant from Super-
Gen, Inc.
Included in ASBMT membership is
a subscription to Biology of Blood
and Marrow Transplantation and
the quarterly bulletin Blood and Mar-
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row Transplantation Reviews. Among
other membership benefits is reduced
member-rate registration at the Tan-
dem BMT Meetings.
Membership applications are avail-
able from the ASBMT Executive Office
and also can be downloaded from
the ASBMT Web site, www.asbmt.
org. Click “Membership Application”
on the home page.
SLIDE PRESENTATION AVAILABLE
ON EVIDENCE-BASED REVIEWS
A new PowerPoint presentation on
evidence-based reviews of stem cell
transplantation for (1) multiple my-
eloma and (2) non-Hodgkin’s lym-
phoma has been posted on the
ASBMT Web site, www.asbmt.org.
The program can be viewed online
or downloaded for presentations
to managed care representatives
and other health care plan decision
makers.
2003–2004 ASBMT DIRECTORIES
MAILED TO SOCIETY MEMBERS
The 2003–2004 ASBMT Member-
ship Directory was mailed in late July
to all members of the Society.
Supported by an educational grant
from Amgen, the directory lists ASBMT
members by name and geographic
location and includes a directory of
North American transplant centers.
NATIONAL CORD BLOOD PROGRAM
FIRST WITH FACT ACCREDITATION
The National Cord Blood Program
in New York, under the direction of
Pablo Rubinstein, MD, is the first bank
to earn accreditation by meeting the
NETCORD/FACT international stan-
dards for cord blood banking. This
accreditation applies to all services
and facilities inspected for cord blood
collection, processing, testing, bank-
ing, selection, and release of alloge-
neic, non-directed donations.
Thirty cord blood banks worldwide
have applied for accreditation. Sev-
eral cord blood banks located in Eu-
rope and Asia have submitted appli-




The Foundation for Accreditation
of Cellular Therapy (FACT) will offer a
workshop for facilities preparing for
their inspections on Feb. 12 in Or-
lando in conjunction with the 2004
Tandem BMT Meetings.
The course will explain accredita-
tion requirements, clarify checklist
questions, and assist programs in or-
ganizing for a FACT on-site inspection.




Five BMT facilities have gained first-
time accreditation by the Foundation
for Accreditation of Cellular Therapy
(FACT).
FACT-accredited facilities now total
117, and more than 100 other facili-
ties are in various phases of the ac-
creditation process.
Newly Accredited
The following facilities are the latest
to gain voluntary accreditation.
Allogeneic and autologous mar-
row and peripheral blood progenitor
cell transplantation, including collec-
tion and laboratory processing:
• Cincinnati Children’s Hospital Med-
ical Center, Blood and Marrow
Transplant Group, Cincinnati, Ohio
• Medical University of South Caro-
lina, Blood and Marrow Transplant
Program, Charleston, S.C.
Allogeneic and autologous periph-
eral blood progenitor cell transplanta-
tion, including collection and labora-
tory processing:
• University of Maryland, Greenbaum
Cancer Center Blood and Marrow
Transplant Program, Baltimore, Md.
Autologous peripheral blood pro-
genitor cell transplantation, including
collection and laboratory processing:
• DeKalb Medical Center, Decatur, Ga.
Allogeneic and autologous mar-
row and peripheral blood progenitor
cell collection and processing:
• Hoxworth Blood Center, University
of Cincinnati Medical Center, Cin-
cinnati, Ohio
Accreditation Renewals
Meanwhile, the accreditation re-
newal cycle continues for facilities
that previously achieved FACT accred-
itation. The following facilities have
completed the re-accreditation process.
Autologous peripheral blood pro-
genitor cell transplantation, including
collection and laboratory processing:
• Our Lady of the Lake Regional
Medical Center, Baton Rouge, La.
• Texas Tech University Health Sci-
ences Center, University Medical
Center Blood and Marrow Trans-
plant Program, Lubbock, Texas
Allogeneic and autologous mar-
row and peripheral blood progenitor
cell transplantation, including collec-
tion and laboratory processing:
• Children’s Hospital of Philadelphia,
Philadelphia, Pa.
• Fairview–University Medical Blood
and Marrow Transplant Program,
affiliated with the University of Min-
nesota, Minneapolis, Minn.
• The University of Alabama at Bir-
mingham, Birmingham, Ala.
• Wayne State University, Karmanos
Cancer Institute, Detroit, Mich.
Autologous peripheral blood pro-
genitor cell collection and processing:
• Pacific Northwest Regional Blood
Services, Portland, Ore.
For a complete list of accredited
facilities, visit the FACT Web site at
www.factwebsite.org or call the
FACT Accreditation Office at (402)
561-7555.
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